Eflapegrastim (Rolvedon) for Prevention of Chemotherapy-Induced Febrile Neutropenia

被引：0
|
作者：
不详
机构：
来源：
MEDICAL LETTER ON DRUGS AND THERAPEUTICS | 2023年 / 65卷 / 1677期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Eflapegrastim-xnst (Rolvedon [Spectrum]; previously called Rolontis), a granulocyte colony-stimulating factor (G-CSF) conjugated to an Fc fragment of human IgG4, has been approved by the FDA to decrease the incidence of infection, as manifested by febrile neutropenia, in adults with nonmyeloid malignancies receiving myelosuppressive chemotherapy that can cause clinically significant febrile neutropenia.
引用
收藏
页码：83 / 84
页数：2
相关论文
共 50 条
  • [41] Outcomes in 102 patients that present to the emergency department with chemotherapy-induced febrile neutropenia
    Lim, Joo Han
    Kim, Hoon
    Choi, Woong Gil
    Kim, Kyung Hwan
    Shin, Dong Wun
    Lee, Moon Hee
    TURKISH JOURNAL OF HEMATOLOGY, 2011, 28 (03) : 193 - 197
  • [42] Predicting the Risk of Severe Bacterial Infection in Children With Chemotherapy-Induced Febrile Neutropenia
    Macher, Emilie
    Dubos, Francois
    Garnier, Nathalie
    Delebarre, Mathilde
    De Berranger, Eva
    Thebaud, Estelle
    Mazingue, Francoise
    Leblond, Pierre
    Martinot, Alain
    PEDIATRIC BLOOD & CANCER, 2010, 55 (04) : 662 - 667
  • [43] Predictive factors of poor prognosis in cancer patients with chemotherapy-induced febrile neutropenia
    Ahn, Shin
    Lee, Yoon-Seon
    Chun, Yun-Hee
    Kwon, In-Ho
    Kim, Won
    Lim, Kyung Soo
    Kim, Tae Won
    Lee, Kyoo-Hyung
    SUPPORTIVE CARE IN CANCER, 2011, 19 (08) : 1151 - 1158
  • [44] Economic burden of chemotherapy-induced febrile neutropenia in patients with lymphoma: A systematic review
    Wang, Xiao Jun
    Lopez, Shaun Eric
    Chan, Alexandre
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2015, 94 (02) : 201 - 212
  • [45] Granulocyte colony-stimulating factor (filgrastim) in chemotherapy-induced febrile neutropenia
    Advani, S. H.
    Achreckar, Suvarna
    Thomas, Dennis
    Krishnankutty, Binny
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2010, 31 (03) : 79 - 82
  • [46] Lecture: management of chemotherapy-induced febrile neutropenia; guidelines and colony stimulating factors
    Giuseppe Procopio
    Monica Niger
    Isabella Testa
    Neurological Sciences, 2011, 32 : 217 - 219
  • [47] Incidence, Treatment, and Consequences of Chemotherapy-Induced Febrile Neutropenia in Inpatient and Outpatient Settings
    Weycker, Derek
    Barron, Richard
    Kartashov, Alex
    Legg, Jason C.
    Lyman, Gary H.
    BLOOD, 2012, 120 (21)
  • [48] Chronic Comorbidities and Chemotherapy-Induced Febrile Neutropenia (FN) in Breast Cancer Patients
    Chia, Victoria M.
    Page, John H.
    Rodriguez, Roberto
    Yang, Su-Jau
    Huyhn, Julie
    McGuire, Michelle
    Chao, Chun
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 467 - 467
  • [49] Incidence, treatment, and consequences of chemotherapy-induced febrile neutropenia in the inpatient and outpatient settings
    Weycker, Derek
    Barron, Richard
    Kartashov, Alex
    Legg, Jason
    Lyman, Gary H.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2014, 20 (03) : 190 - 198
  • [50] Management of chemotherapy-induced neutropenia
    Blundell, Bernardette
    Azzopardi, Lilian M.
    Serracino-Inglott, Anthony
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2015, 37 (01) : 241 - 241
12345